Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$0.45
NASDAQLPCN
Open
$0.47
Change
-$0.02 (-4.23%)
Day's Range
$0.44 - $0.47
52-Week Range
$0.32 - $3.46
Volume
163.9K
Market Cap
$16.1M